Search
Quote for "exact phrases"
       
Sort order:    
Results 1 - 50 of 1002

World Schizophrenia Day: Education & Resources
This Month in Psychpharmacology added 05/23/2026. CME credit is not available

Children’s Mental Health Awareness Day
This Month in Psychpharmacology added 05/07/2026. CME credit is not available

Choosing an Adjunctive Antipsychotic for Major Depressive Disorder
This Month in Psychpharmacology added 05/06/2026. CME credit is not available

FDA Approves Dextromethorphan-Bupropion for Treatment of Agitation in Alzheimer Disease
This Month in Psychpharmacology added 04/30/2026. CME credit is not available

Recommendations for the Deprescribing of Psychotropic Medications
This Month in Psychpharmacology added 04/27/2026. CME credit is not available

Sleep EEG Brain Age Emerges as Possible Early Marker for Dementia Risk
This Month in Psychpharmacology added 04/27/2026. CME credit is not available

A Review of Evidence Reveals Minimal Support for Cannabinoids in Psychiatric Care
This Month in Psychpharmacology added 04/17/2026. CME credit is not available

Predicting Substance Use Behaviors with Machine Learning
This Month in Psychpharmacology added 04/17/2026. CME credit is not available

Efficacy of the Neuroplastogen TSND-201 for the Treatment of PTSD
This Month in Psychpharmacology added 04/17/2026. CME credit is not available

Psilocybin Shows Greater Efficacy Than Nicotine Patches in Smoking Cessation Pilot Trial
This Month in Psychpharmacology added 04/15/2026. CME credit is not available

Esketamine for Depressed Adolescents at Imminent Suicide Risk
This Month in Psychpharmacology added 04/07/2026. CME credit is not available

Clozapine After Failed Drug Trial in First-Episode Psychosis
This Month in Psychpharmacology added 04/06/2026. CME credit is not available

From Awareness to Action: World Bipolar Day
This Month in Psychpharmacology added 03/30/2026. CME credit is not available

FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder
This Month in Psychpharmacology added 03/24/2026. CME credit is not available

Rethinking Mood Disorder Treatment with Immunometabolic Insights
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Brain Awareness Week: March 16-22, 2026
This Month in Psychpharmacology added 03/16/2026. CME credit is not available

FDA Accepts New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension
This Month in Psychpharmacology added 03/09/2026. CME credit is not available

Ketogenic Diet Shows Modest Short-Term Benefit in Treatment-Resistant Depression
This Month in Psychpharmacology added 03/05/2026. CME credit is not available

Long-Term Impact of Cognitive Training on Dementia Risk: 20-Year Outcomes From a Randomized Trial
This Month in Psychpharmacology added 03/03/2026. CME credit is not available

Preinjury Antidepressant Use Does Not Appear to Worsen Clinical Outcomes after TBI
This Month in Psychpharmacology added 02/27/2026. CME credit is not available

FDA Approves Milsaperidone for Schizophrenia and Acute Bipolar I Disorder
This Month in Psychpharmacology added 02/20/2026. CME credit is not available

Metformin Modestly Reduces BMI in Overweight Youth With Bipolar Disorders
This Month in Psychpharmacology added 02/13/2026. CME credit is not available

Serial Intravenous Ketamine Infusions Not Superior to Usual Inpatient Care for Depression
This Month in Psychpharmacology added 02/10/2026. CME credit is not available

Efficacy and Tolerability of Antipsychotics for Acute Schizophrenia
This Month in Psychpharmacology added 02/05/2026. CME credit is not available

Management Strategies for Common Psychotropic Side Effects
MPP: Articles added 02/03/2026. CME credit is available

FDA Grants Priority Review to Centanafadine for ADHD
This Month in Psychpharmacology added 01/28/2026. CME credit is not available

FDA Removes Suicidal Ideation Warning From GLP-1 Drugs
This Month in Psychpharmacology added 01/28/2026. CME credit is not available

Synthetic THC Shows Promise for Agitation Management in Alzheimer’s Patients
This Month in Psychpharmacology added 01/22/2026. CME credit is not available

NRX-101 Development Expanded to Include TMS for Depression
This Month in Psychpharmacology added 01/15/2026. CME credit is not available

FDA Approves Cariprazine for Pediatric Schizophrenia and Bipolar I Disorder
This Month in Psychpharmacology added 01/13/2026. CME credit is not available

Concurrent Metformin Use Linked to Better Adherence to Antipsychotics
This Month in Psychpharmacology added 01/06/2026. CME credit is not available

Preventing PTSD in Deploying Soldiers Using Attention Bias Modification
This Month in Psychpharmacology added 01/06/2026. CME credit is not available

Solutions to Common Issues in the Use of Long-Acting Injectable Antipsychotics
CNS Spectrums added 12/31/2025. CME credit is available

Understanding Long-Acting Injectable Antipsychotics in the Context of Treatment Planning: Crafting a Strategy
CNS Spectrums added 12/31/2025. CME credit is available

Long-Acting Injectable Antipsychotics for Patients With First-Episode and Early-Phase Schizophrenia: Still Not Considered Often Enough
CNS Spectrums added 12/28/2025. CME credit is available

Lies and LAIs: Why Accuracy of Information is the Key to Understanding the Benefits and the Resistance to Using Long-acting Formulation
CNS Spectrums added 12/27/2025. CME credit is available

Prescribing LAIs: From Completing the First Injection to Going Steady
CNS Spectrums added 12/26/2025. CME credit is available

Choosing Amongst the Long-Acting Injectable Antipsychotics: An Evidence-Based Pragmatic Guide
CNS Spectrums added 12/24/2025. CME credit is available

This Year in Psychopharmacology - 2025
MPP: Articles added 12/23/2025. CME credit is available

Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Cannabidiol Fails to Protect Against Cannabis-Induced Symptoms in Schizophrenia
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Novel Benzodiazepines Linked to More Severe Opioid Overdoses
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Starting Benzodiazepines, Antipsychotics in Hospice with Dementia Linked to Increased Mortality
This Month in Psychpharmacology added 12/10/2025. CME credit is not available

Relapse Criteria in Schizophrenia
This Month in Psychpharmacology added 12/02/2025. CME credit is not available

Brief Cognitive Behavioral Therapy Shows Promise for Suicide Prevention in Military Populations
This Month in Psychpharmacology added 11/18/2025. CME credit is not available

Young Investigator Poster Awards
This Month in Psychpharmacology added 11/07/2025. CME credit is not available

FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
This Month in Psychpharmacology added 11/06/2025. CME credit is not available

Child and Adolescent Psychiatry Academy
This Month in Psychpharmacology added 11/05/2025. CME credit is not available

<< Back   1 2 3 4 5 6 7 8 9 10 ...   Next >>